Press Releases

7/1/2010 Javelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.	8.6 KB
6/21/2010 News Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as Issuer	9.6 KB
6/11/2010 Javelin Receives $2 Million Loan from Hospira	8.3 KB
6/7/2010 Javelin Receives Notice from Hospira of Funding of Loan	9.3 KB
6/4/2010 Javelin Receives Notice From NYSE Amex LLC of Non-Compliance	9.6 KB
6/3/2010 Javelin Commences Litigation against Hospira and Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreement and Specific Performance Provision Compels Completion of Merger	10.2 KB
5/24/2010 Javelin Pharmaceuticals, Inc. Provides Update to Dyloject(TM) UK Supply Chain	9.7 KB
5/19/2010 Javelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by Hospira	10.2 KB
5/10/2010 Javelin Pharmaceuticals, Inc. Reports First Quarter 2010 Results	18.2 KB
4/19/2010 Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders	7.3 KB
4/19/2010 Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer	10.7 KB
4/12/2010 Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals	12.6 KB
3/15/2010 Javelin Pharmaceuticals Sets Date for its Special Stockholder Meeting to Approve Proposed Merger with Myriad Pharmaceuticals, Inc.	11.5 KB
3/9/2010 Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2009	20.0 KB
2/17/2010 Javelin Pharmaceuticals' Receives FDA PDUFA Date for Dyloject(TM) NDA	12.7 KB
2/11/2010 Third Party Reexamination of Javelin Pharmaceuticals' Phase III Trial Data for Ereska (Intranasal Ketamine) Yields Statistically Significant Primary Endpoint	16.1 KB
2/2/2010 FDA Accepts Javelin Pharmaceuticals' Dyloject(TM) New Drug Application for Formal Review	14.9 KB
12/18/2009 Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals	23.5 KB
12/2/2009 Javelin Pharmaceuticals Submits Dyloject(TM) New Drug Application to FDA for Management of Acute Moderate-to-Severe Pain in Adults	10.9 KB
11/10/2009 Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results	15.3 KB
Showing 1-20 of 156 releases Page: 1 2 3 4 5 6 7 8  See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.